Hexarelin 5 mg

Hexarelin 5 mg is a synthetic growth hormone-releasing peptide (GHRP) that stimulates the pituitary gland to increase the secretion of endogenous growth hormone (GH). It is primarily used in research and performance contexts for its effects on recovery, muscle development, and metabolic function. It is also studied for potential cardioprotective and tissue-repair properties.

How It Works

Hexarelin binds to ghrelin receptors in the hypothalamus and pituitary gland, triggering the release of growth hormone. This elevation in GH may support protein synthesis, fat metabolism, and tissue regeneration. It has also been noted in research for potential effects on cardiovascular function, including support for cardiac tissue repair and performance.

Dosage Overview

Hexarelin is typically administered via subcutaneous injection, often in the abdominal area. Commonly referenced dosing ranges from 1–2 mcg per kg of body weight per injection, given 2–3 times per day depending on protocol. Treatment cycles generally last 4–8 weeks, followed by a break period to reduce receptor desensitization and maintain effectiveness.

Potential Benefits

Hexarelin is associated with increased growth hormone release, improved recovery, enhanced muscle growth, and reduced body fat. It may also support connective tissue strength, energy levels, and skin elasticity. Some research also suggests potential benefits for cardiovascular health and heart tissue protection.

Side Effects and Considerations

Possible side effects include water retention, fatigue, tingling sensations in the extremities, and temporary changes in appetite. In some cases, prolonged use may lead to receptor desensitization or elevations in cortisol or prolactin. Careful dosing and cycling are recommended to maintain responsiveness and minimize risks.